To minimize any damage to blood stem cells from cancer treatment, these stem cells from the bone marrow are removed and preserved before patients receive chemotherapy. The stem cells are then re-infused into the patient after chemotherapy where they migrate to the bone marrow and begin producing new blood cells. Patients with multiple myeloma as well as non-Hodgkin's and Hodgkin's lymphoma may be offered this approach as part of their treatment.